{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:17:16Z","timestamp":1785406636762,"version":"3.56.0"},"reference-count":143,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Complex Oncology Operating Unit, AULSS 3 Serenissima, Mirano","award":["S3180"],"award-info":[{"award-number":["S3180"]}]},{"DOI":"10.13039\/501100003500","name":"University of Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00240q980","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Head and neck squamous cell carcinoma (HNSCC) is characterized by marked intratumoral heterogeneity and complex tumor\u2013immune\u2013stromal interactions, which shape therapeutic response and clinical outcome. Despite extensive transcriptomic efforts, bulk RNA sequencing has faced significant limitations, often failing to generate robust prognostic or predictive biomarkers, highlighting the need for approaches capable of resolving the cellular and spatial complexity of the tumor ecosystem. Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) have refined our understanding of HNSCC biology by enabling high-resolution mapping of malignant, stem-like, immune, and stromal compartments. Three major spatial domains have been defined in HNSCC: tumor core (TC), tumor invasion front (TIF), and leading edge (LE). Each ecosystem exhibits distinct cellular programs that promote immune evasion, tumor dissemination, and therapy resistance, particularly in high-risk clinical settings. In this Review, we integrate recent single-cell and spatial studies and propose a translational framework linking ecosystem architecture with clinical stratification across resectable locally advanced (r-LAD), unresectable locally advanced (u-LAD), and recurrent\/metastatic (R\/M) disease. We further discuss how spatially resolved transcriptomic approaches may support biomarker discovery and hypothesis generation for risk stratification and trial design, while emphasizing that clinical implementation remains limited by cohort size, methodological heterogeneity, and the need for large-scale prospective validation. Finally, we outline key methodological and translational challenges that must be addressed before these technologies can reliably inform precision oncology and decision-making in HNSCC.<\/jats:p>","DOI":"10.3390\/cancers18142223","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:46:47Z","timestamp":1783676807000},"page":"2223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Bulk to Spatially Resolved Single-Cell Omics: Shaping Future Prognostic and Predictive Stratification in Head and Neck Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-9364","authenticated-orcid":false,"given":"Simonetta","family":"Ausoni","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58b, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Casarin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Local Health Unit 3 Serenissima, Mirano Hospital, Via don Giacobbe Sartor 4, 30035 Venezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Azzarello","sequence":"additional","affiliation":[{"name":"Department of Oncology, Local Health Unit 3 Serenissima, Mirano Hospital, Via don Giacobbe Sartor 4, 30035 Venezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A. Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576.","DOI":"10.1038\/nature14129"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV-tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10555-026-10312-7","article-title":"The impact of genomic ancestry on tumor genomics in head and neck squamous cell carcinoma","volume":"45","author":"Ndahayo","year":"2026","journal-title":"Cancer Metastasis Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Barsouk, A., Aluru, J.S., Rawla, P., Saginala, K., and Barsouk, A. (2023). Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med. Sci., 11.","DOI":"10.3390\/medsci11020042"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10555-016-9625-1","article-title":"Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: Current options and emerging perspectives","volume":"35","author":"Ausoni","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Economopoulou, P., De Bree, R., Kotsantis, I., and Psyrri, A. (2019). Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00827"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106799","DOI":"10.1016\/j.oraloncology.2024.106799","article-title":"The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis","volume":"153","author":"Paderno","year":"2024","journal-title":"Oral Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdx299","article-title":"Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II\u2013III trial","volume":"28","author":"Ghi","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer","volume":"39","author":"Brun","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: A randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annonc.2022.10.006","article-title":"Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): A multicenter, randomized, phase II trial","volume":"34","author":"Tao","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): A randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1200\/JCO.21.02198","article-title":"Pembrolizumab alone or with chemotherapy for recurrent\/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: Subgroup analysis by programmed death ligand-1 combined positive score","volume":"40","author":"Burtness","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-24-0281","article-title":"Advanced Human Papillomavirus\u2013Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies","volume":"23","author":"Park","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","article-title":"Single-cell RNA sequencing in cancer: Lessons learned and emerging challenges","volume":"75","author":"Tirosh","year":"2019","journal-title":"Mol. Cell."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s43018-019-0002-1","article-title":"Intratumor heterogeneity reflects clinical disease course","volume":"1","author":"Litchfield","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: The rosetta stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/s41467-024-46912-6","article-title":"Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","article-title":"Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"ref_30","first-page":"1103","article-title":"A New Cancer Ecosystem","volume":"355","author":"Horning","year":"2017","journal-title":"Am. Assoc. Adv. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cac2.12316","article-title":"The theory of tumor ecosystem","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pudova, E.A., Pavlov, V.S., Guvatova, Z.G., Fedorova, M.S., Shegai, P.V., Kudryavtseva, A.V., and Snezhkina, A.V. (2025). Machine Learning Models for Cancer Research: A Narrative Review of Bulk RNA-Seq Applications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262412081"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/qub2.78","article-title":"Bioinformatics perspectives on transcriptomics: A comprehensive review of bulk and single-cell RNA sequencing analyses","volume":"13","year":"2025","journal-title":"Quant. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13073-022-01075-1","article-title":"An introduction to spatial transcriptomics for biomedical research","volume":"14","author":"Williams","year":"2022","journal-title":"Genome Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s11033-024-09553-y","article-title":"Single-cell transcriptomics: Background, technologies, applications, and challenges","volume":"51","author":"Duhan","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41576-023-00613-w","article-title":"Transitioning single-cell genomics into the clinic","volume":"24","author":"Lim","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","first-page":"282","article-title":"Bioinformatics tools and methods to analyze single-cell RNA sequencing data","volume":"6","author":"Lui","year":"2021","journal-title":"Int. J. Innov. Sci. Res. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00432-024-05816-0","article-title":"Spatial transcriptomics in cancer research and potential clinical impact: A narrative review","volume":"150","author":"Cilento","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ccell.2025.12.009","article-title":"Spatial omics at the forefront: Emerging technologies, analytical innovations, and clinical applications","volume":"44","author":"Liu","year":"2026","journal-title":"Cancer Cell."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s43556-023-00144-0","article-title":"Spatial transcriptomics in development and disease","volume":"4","author":"Zhou","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Nesari, A.M., MotieGhader, H., and Ghorbian, S. (2026). Advances and challenges in single-cell RNA sequencing data analysis: A comprehensive review. Briefings in Bioinformatics, Oxford University Press.","DOI":"10.1093\/bib\/bbaf723"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2519474123","DOI":"10.1073\/pnas.2519474123","article-title":"Spatially resolved multiomics reveals the self-enforcing property of the leading-edge multicellular ecosystem of head and neck cancer","volume":"123","author":"Su","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12957-019-1741-2","article-title":"Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance","volume":"17","author":"Batta","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-21-4316","article-title":"Association of T P53 and CDKN2A mutation profile with tumor mutation burden in head and neck cancer","volume":"28","author":"Deneka","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.21037\/atm-20-6264","article-title":"Molecular landscape of head and neck cancer and implications for therapy","volume":"9","author":"Farah","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Usman, S., Jamal, A., Teh, M.-T., and Waseem, A. (2021). Major molecular signaling pathways in oral cancer associated with therapeutic resistance. Front. Oral Health, 1.","DOI":"10.3389\/froh.2020.603160"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"108580","DOI":"10.1016\/j.mrrev.2025.108580","article-title":"Unveiling Oral Cancer\u2019s Molecular Blueprint: A Novel Classification to Guide Precision Therapy","volume":"797","author":"Pandey","year":"2025","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/ijc.33192","article-title":"Cellular heterogeneity landscape in laryngeal squamous cell carcinoma","volume":"147","author":"Song","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish","year":"2023","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13073-026-01612-2","article-title":"Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer","volume":"18","author":"Ourailidis","year":"2026","journal-title":"Genome Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Baumeister, P., Zhou, J., Canis, M., and Gires, O. (2021). Epithelial-to-mesenchymal transition-derived heterogeneity in head and neck squamous cell carcinomas. Cancers, 13.","DOI":"10.3390\/cancers13215355"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: Targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Huynh, N.C.-N., Huang, T.-T., Nguyen, C.T.-K., and Lin, F.-K. (2022). Comprehensive Integrated single-cell whole transcriptome analysis revealed the p-EMT tumor Cells\u2014CAFs communication in oral squamous cell carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126470"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-022-01646-1","article-title":"A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer","volume":"21","author":"Schinke","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41588-023-01357-3","article-title":"Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma","volume":"55","author":"Puram","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41467-023-37377-0","article-title":"Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer","volume":"14","author":"Bedard","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Xiao, M., Zhang, X., Zhang, D., Deng, S., Zheng, A., Du, F., Shen, J., Yue, L., Yi, T., and Xiao, Z. (2022). Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1050951"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"218015","DOI":"10.1016\/j.canlet.2025.218015","article-title":"Cancer stem cell mechanisms and targeted therapeutic strategies in head and neck squamous cell carcinoma","volume":"634","author":"Maharajan","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/bjc.2014.528","article-title":"SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma","volume":"111","author":"Lee","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1002\/hed.26373","article-title":"Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition","volume":"42","author":"Kashyap","year":"2020","journal-title":"Head. Neck"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Herzog, A.E., Somayaji, R., and N\u00f6r, J.E. (2023). Bmi-1: A master regulator of head and neck cancer stemness. Front. Oral Health, 4.","DOI":"10.3389\/froh.2023.1080255"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Chen, C., Wei, Y., Hummel, M., Hoffmann, T.K., Gross, M., Kaufmann, A.M., and Albers, A.E. (2011). Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016466"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Schulz, A., Meyer, F., Dubrovska, A., and Borgmann, K. (2019). Cancer stem cells and radioresistance: DNA repair and beyond. Cancers, 11.","DOI":"10.3390\/cancers11060862"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.20517\/cdr.2022.107","article-title":"Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma","volume":"6","author":"Siqueira","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer\u2019s molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105420","DOI":"10.1016\/j.oraloncology.2021.105420","article-title":"Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment","volume":"120","author":"Farlow","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1158\/1078-0432.CCR-15-2665","article-title":"CD44+ cells in head and neck squamous cell carcinoma suppress T-cell\u2013mediated immunity by selective constitutive and inducible expression of PD-L1","volume":"22","author":"Lee","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.reth.2021.02.006","article-title":"Immune evasion by cancer stem cells","volume":"17","author":"Tsuchiya","year":"2021","journal-title":"Regen. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/1078-0432.CCR-21-3570","article-title":"Immunostimulatory cancer-associated fibroblast subpopulations can predict immunotherapy response in head and neck cancer","volume":"28","author":"Obradovic","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","article-title":"Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1038\/s41467-021-27619-4","article-title":"Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing","volume":"12","author":"Kulkarni","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-biodatasci-011420-031537","article-title":"Spatial metabolomics and imaging mass spectrometry in the age of artificial intelligence","volume":"3","author":"Alexandrov","year":"2020","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","article-title":"SPP1+ macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41417-023-00704-0","article-title":"SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma","volume":"31","author":"Wu","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models","volume":"26","author":"Greene","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hou, A., Hou, K., Huang, Q., Lei, Y., and Chen, W. (2020). Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00783"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-024-03002-1","article-title":"Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state\u2014Implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e29386","DOI":"10.1002\/jmv.29386","article-title":"Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences","volume":"96","author":"Lee","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Choi, S.-W., Kim, J.H., Hong, J., and Kwon, M. (2025). Mapping immunotherapy potential: Spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1568590"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13046-022-02481-4","article-title":"The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: A multiparametric quantitative and spatial analysis unveils a rationale to target treatment-na\u00efve tumors with immune checkpoint inhibitors","volume":"41","author":"Tosi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41597-023-02611-3","article-title":"Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer","volume":"10","author":"Wang","year":"2023","journal-title":"Sci. Data"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/2326-6066.CIR-22-0454","article-title":"CD161 characterizes an inflamed subset of cytotoxic T lymphocytes associated with prolonged survival in human Papillomavirus\u2013Driven oropharyngeal Cancer","volume":"11","author":"Wei","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"101949","DOI":"10.1016\/j.tranon.2024.101949","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma","volume":"44","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/mco.2025.2916","article-title":"Tertiary lymphoid structure can be a potential therapeutic target for head and neck squamous cell carcinoma","volume":"24","author":"Shen","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Britton, W.R., Cioffi, I., Stonebraker, C., Spence, M., Okolo, O., Martin, C., Henick, B., Nakagawa, H., and Parikh, A.S. (2024). Advancements in TGF-\u03b2 targeting therapies for head and neck squamous cell carcinoma. Cancers, 16.","DOI":"10.3390\/cancers16173047"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1200\/JCO.2020.38.15_suppl.9558","article-title":"Two-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-\u03b2 and PD-L1, for second-line (2L) treatment of non-small cell lung cancer (NSCLC)","volume":"38","author":"Cho","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"oyaf006","DOI":"10.1093\/oncolo\/oyaf006","article-title":"Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection","volume":"30","author":"Redman","year":"2025","journal-title":"Oncologist"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2026.44.16_suppl.TPS6129","article-title":"A multicenter, randomized, double-blind, phase 2\/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: The FORTIFI-HN01 study","volume":"44","author":"Ferrarotto","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/ijo.2025.5719","article-title":"Exploring the antiproliferative effect of PI3K\/Akt\/mTOR pathway and CDK4\/6 inhibitors in human papillomavirus-positive and-negative head and neck squamous cell carcinoma cell lines","volume":"66","author":"Verhees","year":"2025","journal-title":"Int. J. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Munster, P., Mita, M., Mahipal, A., Nemunaitis, J., Massard, C., Mikkelsen, T., Cruz, C., Paz-Ares, L., Hidalgo, M., and Rathkopf, D. (2019). First-in-human phase I study of a dual mTOR kinase and DNA-PK inhibitor (CC-115) in advanced malignancy. Cancer Management and Research, Dove Medical Press.","DOI":"10.2147\/CMAR.S208720"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1004-e926","DOI":"10.1093\/oncolo\/oyac185","article-title":"Inhibition of the phosphatidylinositol-3 kinase pathway using bimiralisib in loss-of-function NOTCH1-mutant head and neck cancer","volume":"27","author":"Johnson","year":"2022","journal-title":"Oncologist"},{"key":"ref_107","first-page":"A624","article-title":"596 Results from a phase 1 study of CDX-1140, a fully human anti-CD40 agonist monoclonal antibody (mAb), in combination with pembrolizumab","volume":"10","author":"Sanborn","year":"2022","journal-title":"BMJ Spec. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-025-07984-4","article-title":"TIGIT in cancer: From mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"S617","DOI":"10.1016\/j.annonc.2024.08.917","article-title":"855P Safety and efficacy of vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo\/pembro) in previously untreated advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II KEYVIBE-005 study","volume":"35","author":"Toullec","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/ijc.31661","article-title":"Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma","volume":"143","author":"Mathios","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1038\/s41467-025-59050-4","article-title":"Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1200\/JCO.2024.42.16_suppl.6038","article-title":"A phase 1 study of fianlimab (anti\u2013LAG-3) in combination with cemiplimab (anti\u2013PD-1) in patients with advanced HNSCC","volume":"42","author":"Cho","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Cierpikowski, P., Leszczyszyn, A., and Bar, J. (2023). The role of hedgehog signaling pathway in head and neck squamous cell carcinoma. Cells, 12.","DOI":"10.3390\/cells12162083"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1038\/s41598-024-54937-6","article-title":"Elucidating Hedgehog pathway\u2019s role in HNSCC progression: Insights from a 6-gene signature","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1200\/JCO.2023.41.16_suppl.9093","article-title":"A phase I trial of sequential dosing of sonidegib and pembrolizumab in advanced solid tumors (aST) and non\u2013small-cell lung cancer (NSCLC)","volume":"41","author":"Shanshal","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.22.02786","article-title":"Personalized biomarker-based umbrella trial for patients with recurrent or metastatic head and neck squamous cell carcinoma: KCSG HN 15-16 TRIUMPH trial","volume":"42","author":"Keam","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.22.01994","article-title":"Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, recurrent\/metastatic head and neck cancer","volume":"41","author":"Bauman","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_118","unstructured":"Marripati, D., Besso, M., Roscher, M., Han, R., Hadiwikarta, W., Elkabets, M., Hess, J., and Kurth, I. (2025). A Unified Single-Cell Atlas of HNSCC: Uncovering HPV and Sex Variability in the Tumor Microenvironment. bioRxiv."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1158\/1078-0432.CCR-22-3563","article-title":"Integrative single-cell and bulk transcriptomes analyses identify intrinsic HNSCC subtypes with distinct prognoses and therapeutic vulnerabilities","volume":"29","author":"Dai","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Elebyary, O., Barbour, A., Fine, N., Tenenbaum, H.C., and Glogauer, M. (2021). The crossroads of periodontitis and oral squamous cell carcinoma: Immune implications and tumor promoting capacities. Front. Oral Health, 1.","DOI":"10.3389\/froh.2020.584705"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Liu, X., Naughton, K., Karsen, S.D., Bentley, P., Duggan, L., Chaudhary, N., Smith, K.M., Phillips, L., Chang, D., and Mahi, N.A. (2026). Probing the Feasibility of Single-Cell Fixed RNA Sequencing from FFPE Tissue. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031605"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1016\/j.cell.2024.09.001","article-title":"Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues","volume":"187","author":"Bai","year":"2024","journal-title":"Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1038\/s41467-025-63414-1","article-title":"Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples","volume":"16","author":"Hernandez","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S1470-2045(24)00507-2","article-title":"Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): An open-label, multicentre, parallel-group, randomised, phase 2\/3 trial","volume":"25","author":"Mell","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(25)01850-1","article-title":"Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): A randomised, open-label, phase 3 trial","volume":"407","author":"Bourhis","year":"2025","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","volume":"393","author":"Uppaluri","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.21037\/tcr-2025-2042","article-title":"Implementing perioperative immunotherapy for head and neck cancer after KEYNOTE-689: Questions and challenges","volume":"14","author":"Brammer","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.21037\/tcr-2025-1-2798","article-title":"Bridging histopathology, inferred transcriptomics, and immunotherapy response prediction in head and neck cancer","volume":"15","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.jobcr.2025.10.015","article-title":"Artificial Intelligence\u2013driven spatial transcriptomics in OSCC: Mapping the tumor microenvironment and personalizing therapy","volume":"15","author":"Manogaran","year":"2025","journal-title":"J. Oral Biol. Craniofacial Res."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zeng, L., Song, G., Peng, G., Chen, Z., Yuan, Y., Chen, T., Zhong, T., Chen, S., and Luo, Z. (2025). A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1551844"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"102715","DOI":"10.1016\/j.xcrm.2026.102715","article-title":"Single-cell analysis highlights the significance of malignant cell IFN\/MHC-II for immunotherapy response in head and neck squamous cell carcinoma","volume":"7","author":"Mints","year":"2026","journal-title":"Cell Rep. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"102024","DOI":"10.1016\/j.xcrm.2025.102024","article-title":"Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1038\/s41467-025-59004-w","article-title":"Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: A phase II trial","volume":"16","author":"Xiang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41698-025-00886-w","article-title":"Multi-omics in immunotherapy research for HNSCC: Present situation and future perspectives","volume":"9","author":"Liu","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wusiman, D., Lombardi Stocchetti, B., Eksioglu, E.A., and Cavalieri, S. (2026). Editorial: Multi-omics in head and neck cancer: Unveiling immunological biomarkers for therapy. Front. Oncol., 16.","DOI":"10.3389\/fonc.2026.1782165"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.clon.2015.07.004","article-title":"Gene expression signatures as biomarkers of tumour hypoxia","volume":"27","author":"Harris","year":"2015","journal-title":"Clin. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Fox, N.S., Starmans, M.H., Haider, S., Lambin, P., and Boutros, P.C. (2014). Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences. BMC Bioinform., 15.","DOI":"10.1186\/1471-2105-15-170"},{"key":"ref_138","first-page":"100234","article-title":"Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures","volume":"2","author":"Hartley","year":"2025","journal-title":"Cell Genom."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12957-023-03284-3","article-title":"Tumor hypoxia and role of hypoxia-inducible factor in oral cancer","volume":"22","author":"Singh","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamaoto.2024.5254","article-title":"Current progress and future directions of immunotherapy in head and neck squamous cell carcinoma: A narrative review","volume":"151","author":"Sim","year":"2025","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"107887","DOI":"10.1016\/j.oraloncology.2026.107887","article-title":"Spatial transcriptomics of immune ecotypes for predicting immunotherapy outcomes in head and neck squamous cell carcinoma","volume":"175","author":"Xin","year":"2026","journal-title":"Oral Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41416-022-01716-7","article-title":"Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)\u2014A personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma","volume":"126","author":"Flach","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41698-026-01309-0","article-title":"Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients","volume":"10","author":"Flach","year":"2026","journal-title":"npj Precis. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T04:20:45Z","timestamp":1783830045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":143,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cancers18142223"],"URL":"https:\/\/doi.org\/10.3390\/cancers18142223","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}